GROWING TOGETHER


Creating the global leader in clinical trial endpoint technology and leading partner to pharmaceutical and biotechnology companies, providing best-in-class technology, scientific and therapeutic expertise, and digital innovation with an unrelenting focus on customer service.

Together we will combine Bioclinica’s expertise in imaging, eClinical software, and drug safety solutions with ERT’s expertise in eCOA, cardiac safety, respiratory and wearables. By joining forces, ERT strengthens the most comprehensive and robust endpoint data collection portfolio in the industry with greater integrated and digital solutions.

ERT & Bioclinica Customer Briefing

GROWING TOGETHER


Creating the global leader in clinical trial endpoint technology and leading partner to pharmaceutical and biotechnology companies, providing best-in-class technology, scientific and therapeutic expertise, and digital innovation with an unrelenting focus on customer service.

Together we will combine Bioclinica’s expertise in imaging, eClinical software, and drug safety solutions with ERT’s expertise in eCOA, cardiac safety, respiratory and wearables. By joining forces, ERT strengthens the most comprehensive and robust endpoint data collection portfolio in the industry with greater integrated and digital solutions across essential endpoints – including imaging, respiratory, cardiac, eCOA with connected devices, as well as precision motion.

ERT & Bioclinica Customer Briefing

Together, extending our global leadership to advance the clinical trial industry



Our combined company is committed to accelerating market leading investments in research and development to bring more integrated endpoint technology, and provide access to a broader team of medical and scientific industry leaders. This integrated approach will improve the clinical trial experience for sites, customers, and patients.

Together, extending our global leadership to advance the clinical trial industry



Our combined company is committed to accelerating market leading investments in research and development to bring more integrated end-point technology, and provide access to a broader team of medical and scientific industry leaders. This integrated approach will improve the clinical trial experience for sites, customers, and patients.

Joe Eazor

“Our newly combined organization delivers on our commitment to accelerate innovation for today’s complex and fast-moving clinical trials environment. This will enable us to be more capable partners to our customers, and, more importantly, enhance our ability to help improve health and save lives.”

– Joe Eazor, President & CEO of ERT

Joe Eazor


“Our newly combined organization delivers on our commitment to accelerate innovation for today’s complex and fast-moving clinical trials environment. This will enable us to be more capable partners to our customers, and, more importantly, enhance our ability to help improve health and save lives.”

– Joe Eazor, President & CEO of ERT

LET’S CONNECT!

Learn more about how ERT and Bioclinica are working together to minimize uncertainty and risk in clinical trials.


LET’S CONNECT!

Learn more about how ERT and Bioclinica are working together to minimize uncertainty and risk in clinical trials.


OUR PROMISE

The integration of the world’s leading clinical trial technology and imaging partners will provide a best-in-class portfolio delivering integrated endpoint technologies and leading decentralization capabilities. We are the leading partner in delivering hybrid trials across the spectrum of traditional sites, alternate locations, and the home. There are a few things you can expect. These include:

Service Continuity and Seamless Transition

All in-progress studies will continue as contracted, customers will not experience any changes or interruptions. We are committed to ensuring high-quality service, and client and project success through all of our execution activities.

Reliable Relationships

Our customers are at the center of what we do and will always be our top priority. You will enjoy your existing relationships as well as expanded capabilities enabled by the combined organizations.

Innovative Solutions & Expertise

Together, we will bring more integrated endpoint technology, provide access to a broader team of medical and scientific industry leaders and accelerate our market leading investments in research and development.

OUR PROMISE

The integration of the world’s leading clinical trial technology and imaging partners will provide a best-in-class portfolio delivering integrated endpoint technologies and leading decentralization capabilities. We are the leading partner in delivering hybrid trials across the spectrum of traditional sites, alternate locations, and the home. There are a few things you can expect. These include:


Service Continuity and Seamless Transition

All in-progress studies will continue as contracted, customers will not experience any changes or interruptions. We are committed to ensuring high-quality service, and client and project success through all of our execution activities.

Reliable
Relationships

Our customers are at the center of what we do and will always be our top priority. You will enjoy your existing relationships as well as expanded capabilities enabled by the combined organizations.

Innovative Solutions
& Expertise

Together, we will bring more integrated endpoint technology, provide access to a broader team of medical and scientific industry leaders and accelerate our market leading investments in research and development.

LET’S CONNECT!

Learn more about how ERT and Bioclinica are working together to minimize uncertainty and risk in clinical trials.


LET’S CONNECT!

Learn more about how ERT and Bioclinica are working together to minimize uncertainty and risk in clinical trials.